Clinical Trial
Janssen Research & Development, LLC · Regeneron Pharmaceuticals · Janssen Korea, Ltd., Korea
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Clinical Trial as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:46 UTC. Showing 200 of 3455. Open this list on ClinicalTrials.gov
- N/ANCT07915232 · A Study to Assess Pregnancy, Neonatal and Infant Outcomes in Participants Exposed to NipocalimabJanssen Research & Development, LLC · not yet recruiting · Pregnancy Related, Pregnancy, Pregnancy High-risk · study director
- Ph3NCT07906717 · A Study of JNJ-101556143 With Best Supportive Care in Participants With Metastatic Prostate CancerJanssen Research & Development, LLC · recruiting · Prostatic Neoplasms · study director
- Ph3NCT07903272 · A Trial Comparing Ramantamig and Daratumumab (Ramantamig-D) Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant EligibleJanssen Research & Development, LLC · not yet recruiting · Multiple Myeloma · study director
- Ph3NCT07901725 · Linvoseltamab Versus Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone (Dara-Vcd) in Adult Participants With Newly Diagnosed Systemic Light Chain AmyloidosisRegeneron Pharmaceuticals · not yet recruiting · Newly Diagnosed Amyloidosis, Amyloidosis Stage I-IIIA · study director
- Ph3NCT07896265 · Efficacy And Safety of Olatorepatide in Adults With Overweight or Obesity Without DiabetesRegeneron Pharmaceuticals · not yet recruiting · Overweight or Obesity Without Diabetes · study director
- N/ANCT07890285 · A Study of Opsynvi in Adults Participants With Pulmonary Arterial Hypertension in KoreaJanssen Korea, Ltd., Korea · not yet recruiting · Pulmonary Arterial Hypertension · study director
- Ph1/Ph2NCT07887750 · REGN9220 in Combination With Odronextamab in Adult Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphomas (BCNHLs)Regeneron Pharmaceuticals · not yet recruiting · Diffuse Large B-Cell Lymphoma (DLBCL) · study director
- Ph3NCT07876492 · A Study to Evaluate Cenvacibart (REGN7508) for Secondary Stroke Prevention in Adult ParticipantsRegeneron Pharmaceuticals · not yet recruiting · Secondary Stroke · study director
- Ph1NCT07876505 · Healthy Adult Participants Trial Comparing Different Cenvacibart PresentationsRegeneron Pharmaceuticals · not yet recruiting · Healthy Volunteers · study director
- Ph1/Ph2NCT07863024 · Safety and Efficacy Study in Adults With Advanced Solid Tumors Receiving REGN13089-M404-M2980, an Antibody-drug Conjugate That Targets MET Protein on TumorsRegeneron Pharmaceuticals · not yet recruiting · Advanced Solid Tumors · study director
- Ph1NCT07861152 · Thyroid-Stimulating Hormone Receptor (TSHR) Blockade With REGN24493 in Adult Participants With Graves' Disease (GD)Regeneron Pharmaceuticals · not yet recruiting · Graves' Disease · study director
- Ph3NCT07854782 · Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Regeneron Pharmaceuticals · recruiting · Metabolic Dysfunction-Associated Steatotic Liver Disease, MASLD · study director
- Ph3NCT07856420 · A Study of JNJ-99245354 (ITI-1284) as an Adjunctive Treatment in Participants With Generalized Anxiety Disorder (GAD) Who Have an Inadequate Response to GAD TreatmentIntra-Cellular Therapies, Inc. · recruiting · Generalized Anxiety Disorder · study director
- N/ANCT07851207 · A Study to Assess Guselkumab in Participants With Moderate-to-Severe Inflammatory Bowel Disease in Real Life Italian SettingJanssen-Cilag Ltd. · not yet recruiting · Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases · study director
- N/ANCT07848737 · A Real-World Study of Guselkumab Persistence and Effectiveness in Participants With Crohn's Disease or Ulcerative ColitisJanssen-Cilag, S.A. · not yet recruiting · Colitis, Ulcerative, Crohn Disease · study director
- Ph1/Ph2NCT07850921 · REGN21353 Alone or in Combination With Nezastomig for Metastatic Castration-Resistant Prostate Cancer in Adult ParticipantsRegeneron Pharmaceuticals · not yet recruiting · Metastatic Castration-Resistant Prostate Cancer, mCRPC · study director
- N/ANCT07845682 · A Study of Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter With TRUPULSE™ Generator in Persistent Atrial FibrillationBiosense Webster, Inc. · recruiting · Atrial Fibrillation · study director
- Ph1/Ph2NCT07832370 · A Trial of ALN-6457 in Adult Participants With Symptomatic Prion Disease (PrD)Regeneron Pharmaceuticals · not yet recruiting · Prion Disease · study director
- Ph2NCT07832292 · A Study of JNJ-101556143 in Participants With Metastatic Prostate CancerJanssen Research & Development, LLC · recruiting · Prostatic Neoplasms · study director
- Ph2NCT07830329 · Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or ObesityRegeneron Pharmaceuticals · recruiting · Hidradenitis Suppurativa · study director
- N/ANCT07822529 · A Study of Long Term Persistency of Guselkumab in Adult Participants With Inflammatory Bowel DiseaseJanssen Research & Development, LLC · recruiting · Inflammatory Bowel Diseases · study director
- N/ANCT07819305 · Evaluation of Approved Contact Lenses (CR-6657)Johnson & Johnson Vision Care, Inc. · active not recruiting · Visual Acuity · study director
- Ph2NCT07808515 · A Study Comparing Cemiplimab-based Treatments for Adult Participants With Locally Advanced Basal Cell Skin Cancer (laBCC)Regeneron Pharmaceuticals · not yet recruiting · Locally Advanced Basal Cell Carcinoma · study director
- Ph3NCT07807865 · A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)Intra-Cellular Therapies, Inc. · recruiting · Generalized Anxiety Disorder · study director
- N/ANCT07788989 · A Study to Predict Atrial Fibrillation (AF) Burden in Participants With PAF and PsAF Treated With the VARIPULSE™ PFA CatheterBiosense Webster, Inc. · not yet recruiting · Atrial Fibrillation · study director
- N/ANCT07788521 · Comparison of ACUVUE® OASYS MAX 1-Day Multifocal and DAILIES® AquaComfort Plus® MultifocalJohnson & Johnson Vision Care, Inc. · recruiting · Visual Acuity · study director
- N/ANCT07784387 · A Study to Characterize High-Risk Non-Muscle-Invasive Bladder Cancer Participants in PortugalJanssen-Cilag Farmaceutica Ltda. · recruiting · Urinary Bladder Neoplasms · study director
- N/ANCT07782619 · Agreement of Two OCT Biometers: A Pilot StudyAlcon Research · recruiting · Anterior Segment of Eye, Axial Length, Biometrics Measurement · study director
- N/ANCT07768735 · UNITY DX Cornea StudyAlcon Research · recruiting · Tomography · study director
- Ph1NCT07759167 · Study of 3 Monoclonal Antibodies (REGN9933, REGN7508, and REGN9533) in Adult Participants With End-Stage Kidney Disease on HemodialysisRegeneron Pharmaceuticals · recruiting · End-Stage Kidney Disease (ESKD) · study director
- N/ANCT07760649 · A Study to Monitor Safety and Effectiveness of Approved J&J MedTech Devices in the Treatment of Participants With Ischemic StrokeNeuravi Limited · not yet recruiting · Ischemic Stroke · study director
- N/ANCT07758790 · A Registry Study to Assess SYNTHECELTM Dura RepairDePuy Synthes Products, Inc. · not yet recruiting · Craniotomy · study director
- Ph1NCT07753148 · Safety and Tolerability of REGN17235 in Adult Participants With Clonal Cytopenia of Undetermined Significance and Low-Risk Myelodysplastic Syndrome With SF3B1 MutationRegeneron Pharmaceuticals · recruiting · Clonal Cytopenia of Undetermined Significance (CCUS), Low-Risk Myelodysplastic Syndrome (LR-MDS) · study director
- Ph2NCT07746687 · A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe AsthmaJanssen Research & Development, LLC · recruiting · Asthma · study director
- Ph3NCT07747389 · A Study of Lumateperone Versus Placebo in Participants With Major Depressive DisorderIntra-Cellular Therapies, Inc. · not yet recruiting · Depressive Disorder, Major · study director
- Ph1NCT07746713 · A Study of JNJ-98768111 in Participants With Advanced Prostate CancerJanssen Research & Development, LLC · recruiting · Prostatic Neoplasms · study director
- N/ANCT07746583 · A Study of Guselkumab Given After Ustekinumab in Participants With Moderate to Severe Psoriasis in Routine Clinical PracticeJanssen-Cilag Kft. · recruiting · Psoriasis · study director
- N/ANCT07746765 · A Study of Continued Use of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis in Real World SettingJanssen Sciences Ireland UC · not yet recruiting · Crohn Disease, Colitis, Ulcerative · study director
- N/ANCT07735793 · A Real-world Study in Participants With High-risk Non-Muscle-Invasive Bladder Cancer After Bacillus Calmette-Guérin Therapy in KoreaJanssen Korea, Ltd., Korea · recruiting · Urinary Bladder Neoplasms · study director
- N/ANCT07727057 · A Study of Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter With the TRUPULSE™ Generator for Treatment of Ventricular ArrhythmiasBiosense Webster, Inc. · recruiting · Arrhythmias, Cardiac · study director
- Ph3NCT07716098 · A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant DepressionJanssen Research & Development, LLC · recruiting · Depressive Disorder, Treatment-Resistant · study director
- N/ANCT07710846 · A Study to Identify and Characterize Adults and Pediatric Participants With Cat and/or Birch AllergyRegeneron Pharmaceuticals · not yet recruiting · Conjunctivitis Allergic · study director
- Ph3NCT07697599 · Venous Thromboembolism (VTE) Prophylaxis With REGN7508 and REGN9933 in Adult and Adolescent Participants With a Peripherally Inserted Central Catheter (PICC)Regeneron Pharmaceuticals · recruiting · Venous Thromboembolism (VTE) · study director
- Ph1NCT07682818 · Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic FunctionZealand Pharma · recruiting · Impaired Hepatic Function · principal investigator
- Ph2NCT07685808 · Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without DiabetesRegeneron Pharmaceuticals · recruiting · Overweight or Obesity · study director
- N/ANCT07680907 · A Real World Study of Participants With Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor Mutation (EGFRm)Janssen-Cilag Farmaceutica Ltda. · not yet recruiting · Carcinoma, Non-Small-Cell Lung · study director
- Ph3NCT07675811 · A Study to Evaluate the Efficacy and Safety of Fel d 1 Monoclonal Antibodies in Adult and Pediatric Participants With Allergic Conjunctivitis Due to Cat AllergyRegeneron Pharmaceuticals · recruiting · Allergic Conjunctivitis · study director
- Ph1/Ph2NCT07675824 · REGN22530 for Adults With Primary Open Angle Glaucoma or Ocular HypertensionRegeneron Pharmaceuticals · recruiting · Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OHT) · study director
- Ph1NCT07669077 · A Study to Assess Nipocalimab Concentrations in Breast Milk of Healthy Lactating WomenJanssen Research & Development, LLC · recruiting · Healthy · study director
- Ph3NCT07665450 · A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not PlannedJanssen Research & Development, LLC · recruiting · Multiple Myeloma · study director
- Ph4NCT07654751 · A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA TherapeuticallyJanssen Research & Development, LLC · recruiting · Psoriasis, Colitis, Ulcerative, Crohn Disease · study director
- Ph2NCT07631637 · Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)Regeneron Pharmaceuticals · recruiting · Metabolic Dysfunction-Associated Steatohepatitis, MASH · study director
- Ph3NCT07626411 · Stroke and Systemic Embolism Prevention in Adult Participants With Atrial FibrillationRegeneron Pharmaceuticals · recruiting · Atrial Fibrillation (AF) · study director
- Ph1NCT07615426 · A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With SchizophreniaJanssen Research & Development, LLC · recruiting · Schizophrenia · study director
- Ph4NCT07609940 · Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)Regeneron Pharmaceuticals · recruiting · Relapsed/Refractory Multiple Myeloma (RRMM) · study director
- N/ANCT07606339 · A Study of Guselkumab in Participants With Crohn's Disease and Ulcerative ColitisJanssen-Cilag Pharma GmbH · recruiting · Crohn Disease, Colitis, Ulcerative · study director
- N/ANCT07602088 · A Real-world Study of Ibrutinib and Venetoclax (I+V) First-Line Treatment Given for Fixed-duration of Time in Participants With Chronic Lymphocytic LeukemiaJanssen Research & Development, LLC · recruiting · Leukemia, Lymphocytic, Chronic, B-Cell · study director
- Ph1/Ph2NCT07594106 · REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell CarcinomaRegeneron Pharmaceuticals · recruiting · Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC) · study director
- Ph1NCT07594093 · Safety and Drug Concentrations of REGN20934 in Adults With Overweight or ObesityRegeneron Pharmaceuticals · recruiting · Overweight or Obesity · study director
- Ph2NCT07589634 · A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple MyelomaJanssen Research & Development, LLC · recruiting · Multiple Myeloma · study director
- N/ANCT07587138 · Clinical Evaluation of a Novel Trifocal IOLAlcon Research · recruiting · Aphakia, Cataract · study director
- Ph2NCT07586202 · A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLCJanssen Research & Development, LLC · recruiting · Carcinoma, Non-Small-Cell Lung · study director
- Ph4NCT07587658 · This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring HospitalizationRegeneron Pharmaceuticals · recruiting · Chronic Obstructive Pulmonary Disease (COPD) · study director
- N/ANCT07582783 · A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in RomaniaJanssen Research & Development, LLC · recruiting · Psoriasis · study director
- Ph3NCT07577843 · A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's DiseaseJanssen Research & Development, LLC · recruiting · Crohn Disease · study director
- Ph3NCT07578363 · An Investigation of FID 123472 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness in AdultsAlcon Research · recruiting · Ocular Hyperemia · study director
- Ph3NCT07577856 · A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative ColitisJanssen Research & Development, LLC · recruiting · Colitis, Ulcerative · study director
- Ph3NCT07573176 · A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive DisorderJanssen Research & Development, LLC · recruiting · Depressive Disorder, Major · study director
- Ph1NCT07572006 · A Study of JNJ-95804306 for Relapsed or Refractory Hematological MalignanciesJanssen Research & Development, LLC · recruiting · Hematologic Neoplasms · study director
- Ph1/Ph2NCT07567469 · A Safety and Efficacy Study of Combined Fianlimab + Cemiplimab in Children and Young Adults With Recurrent or Progressive High-Grade Glioma or Posterior Fossa-A EpendymomaRegeneron Pharmaceuticals · not yet recruiting · High-Grade Glioma (HGG), Posterior Fossa-A Ependymoma · study director
- N/ANCT07567092 · A Study of VIRTUGUIDE System and DePuy Synthes Lapidus Implant in Participants Undergoing Lapidus ProcedureDePuy Synthes Products, Inc. · recruiting · Hallux Valgus · study director
- Ph3NCT07559513 · A Study to Investigate the Safety, Pharmacokinetics (PK), and Efficacy of Garetosmab in Children and Adolescents With Fibrodysplasia Ossificans Progressiva (FOP)Regeneron Pharmaceuticals · not yet recruiting · Fibrodysplasia Ossificans Progressiva, FOP · study director
- N/ANCT07540884 · Evaluation of Tears Naturale® Free and Tears Naturale® II Lubricant Eye DropsAlcon Research · completed · Dry Eye Disease · study director
- Ph1NCT07543055 · A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has SpreadRegeneron Pharmaceuticals · recruiting · Prostate Cancer · study director
- N/ANCT07532226 · A Study of Guselkumab Treatment Persistence in Psoriatic Arthritis ParticipantsJanssen-Cilag Ltd. · recruiting · Arthritis, Psoriatic · study director
- Ph2NCT07527910 · A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLDRegeneron Pharmaceuticals · recruiting · Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) · study director
- N/ANCT07527299 · A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava IsolationBiosense Webster, Inc. · recruiting · Atrial Fibrillation · study director
- Ph1NCT07527923 · First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic DermatitisRegeneron Pharmaceuticals · recruiting · Healthy Volunteer, Atopic Dermatitis · study director
- Ph1NCT07524855 · A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast CancerJanssen Research & Development, LLC · recruiting · Metastatic Breast Cancer · study director
- Ph1NCT07525141 · A Study of JNJ-1761981 in Participants With Solid TumorsJohnson & Johnson Enterprise Innovation Inc. · recruiting · Neoplasms · study director
- N/ANCT07523750 · A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial FibrillationBiosense Webster, Inc. · recruiting · Atrial Fibrillation · study director
- Ph1NCT07526116 · A First in Human Study to Assess Safety, Tolerability and Pharmacokinetics of a Single Dose of REGN22044 in Healthy AdultsRegeneron Pharmaceuticals · recruiting · Healthy Volunteer · study director
- N/ANCT07520747 · A Database Study of Disease, Treatment Patterns and Healthcare Use in Children With Inflammatory Bowel Diseases in KoreaJanssen Korea, Ltd., Korea · active not recruiting · Inflammatory Bowel Diseases · study director
- Ph3NCT07518186 · A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple MyelomaJanssen Research & Development, LLC · recruiting · Multiple Myeloma · study director
- N/ANCT07511166 · A Study of Varipulse Catheter in Participants With Paroxysmal Atrial Fibrillation Under Optimized SedationJohnson & Johnson Medical (Shanghai) Ltd. · recruiting · Atrial Fibrillation · study director
- N/ANCT07502456 · Clareon TruPlus StudyAlcon Research · recruiting · Aphakia, Astigmatism · study director
- Ph3NCT07499232 · A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's DiseaseJanssen Research & Development, LLC · recruiting · Crohn Disease · study director
- Ph3NCT07493304 · Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic CancersRegeneron Pharmaceuticals · recruiting · Venous Thromboembolism (VTE) · study director
- N/ANCT07484191 · Contralateral Claims Study of Clareon Vivity ProAlcon Research · active not recruiting · Aphakia, Presbyopia · study director
- Ph2NCT07477704 · A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have HypercholesterolemiaRegeneron Pharmaceuticals · active not recruiting · Hypercholesterolemia · study director
- Ph1/Ph2NCT07455851 · A Trial to Study if REGN17372 in Combination With Linvoseltamab is Tolerable for Adult Participants With Relapsed/Refractory Multiple MyelomaRegeneron Pharmaceuticals · recruiting · Relapsed Refractory Multiple Myeloma (RRMM) · study director
- N/ANCT07451002 · A Study to Assess Adherence to Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer Participants in FranceJanssen Cilag S.A.S. · recruiting · Prostatic Neoplasms, Metastatic Hormone-sensitive Prostate Cancer · study director
- N/ANCT07449234 · A Study of Guselkumab After Switching From Ustekinumab in Participants With Moderate to Severe PsoriasisJanssen-Cilag Ltd. · terminated · Psoriasis · study director
- N/ANCT07443215 · Evaluation of Effect of Scatter on Visual PerformanceJohnson & Johnson Vision Care, Inc. · completed · Visual Acuity · study director
- Ph3NCT07438496 · A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus ErythematosusJanssen Research & Development, LLC · recruiting · Lupus Erythematosus, Systemic · study director
- N/ANCT07429214 · A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAFBiosense Webster, Inc. · active not recruiting · Atrial Fibrillation · study director
- Ph3NCT07430956 · Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is UnsuitableRegeneron Pharmaceuticals · recruiting · Atrial Fibrillation (AF) · study director
- Ph2NCT07431086 · Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the USRegeneron Pharmaceuticals · active not recruiting · Overweight or Obesity · study director
- Ph2/Ph3NCT07428369 · A Study of Linvo-VR vs DVRd in Transplant-Eligible Adult Participants With Newly Diagnosed Multiple Myeloma (NDMM)Regeneron Pharmaceuticals · withdrawn · Multiple Myeloma (MM) · study director
- N/ANCT07428564 · A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE PRO Software in Participants With PsAFBiosense Webster, Inc. · active not recruiting · Atrial Fibrillation · study director
- Ph3NCT07410117 · REGN7508 in Adult Participants for Prevention of Cancer-Associated ThrombosisRegeneron Pharmaceuticals · recruiting · Cancer-Associated Thrombosis (CAT) · study director
- Ph3NCT07393282 · A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)Regeneron Pharmaceuticals · recruiting · High Risk Smoldering Multiple Myeloma (HR-SMM) · study director
- Ph2NCT07321873 · A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic ArthritisJanssen Research & Development, LLC · active not recruiting · Arthritis, Psoriatic · study director
- Ph3NCT07318610 · Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery DiseaseRegeneron Pharmaceuticals · recruiting · Peripheral Artery Disease (PAD) · study director
- Ph1NCT07319871 · A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate CancerJanssen Research & Development, LLC · recruiting · Prostatic Neoplasms · study director
- Ph2NCT07318597 · Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)Regeneron Pharmaceuticals · recruiting · Pulmonary Arterial Hypertension (PAH) · study director
- N/ANCT07309445 · A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United StatesJanssen Research & Development, LLC · recruiting · Non-Muscle Invasive Bladder Neoplasms · study director
- Ph4NCT07310095 · A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)Xian-Janssen Pharmaceutical Ltd. · recruiting · Crohn Disease · study director
- Ph3NCT07309432 · Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen AllergyRegeneron Pharmaceuticals · terminated · Allergic Conjunctivitis · study director
- Ph1NCT07308132 · A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid MalignanciesJanssen Research & Development, LLC · recruiting · Lymphoma, Non-Hodgkin · study director
- N/ANCT07302360 · A Real-World Study of Guselkumab in Chinese Participants With Ulcerative ColitisXian-Janssen Pharmaceutical Ltd. · recruiting · Colitis, Ulcerative · study director
- N/ANCT07298317 · Safety and Performance of the OTTAVA System in Participants Undergoing Inguinal Hernia RepairAuris Health, Inc. · completed · Hernia, Inguinal · study director
- Ph1NCT07295951 · A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute LeukemiaJanssen Research & Development, LLC · completed · Acute Lymphoblastic Leukemia, Acute Leukemias, Acute Myeloid Leukemia · study director
- Ph3NCT07276399 · A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck CancerJanssen Research & Development, LLC · recruiting · Squamous Cell Carcinoma of Head and Neck · study director
- Ph2NCT07271186 · Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney DiseaseRegeneron Pharmaceuticals · recruiting · Diabetic Kidney Disease (DKD) · study director
- N/ANCT07242248 · A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)Janssen-Cilag Ltd. · recruiting · Inflammatory Bowel Disease, Colitis, Ulcerative, Crohn's Disease · study director
- N/ANCT07238699 · An Evaluation of the Safety and Tolerability of Ocular LubricantsAlcon Research · completed · Dry Eye Disease · study director
- Ph2NCT07235917 · A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic AmenorrheaRegeneron Pharmaceuticals · recruiting · Functional Hypothalamic Amenorrhea, FHA · study director
- N/ANCT07230691 · A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World SettingJanssen Research & Development, LLC · recruiting · Carcinoma, Non-Small-Cell Lung · study director
- Ph1NCT07230834 · Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult ParticipantsRegeneron Pharmaceuticals · recruiting · Geographic Atrophy (GA) · study director
- Ph2NCT07230860 · A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic DermatitisJanssen Research & Development, LLC · active not recruiting · Dermatitis, Atopic · study director
- N/ANCT07228312 · A Study of Choydar Flow-Directed Mesh Stent in the Treatment of Unruptured Intracranial AneurysmsJohnson & Johnson Medical (Shanghai) Ltd. · recruiting · Intracranial Aneurysm · study director
- N/ANCT07227532 · A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter SystemBiosense Webster, Inc. · recruiting · Atrial Fibrillation · study director
- Ph1/Ph2NCT07227025 · A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung CancerJanssen Research & Development, LLC · recruiting · Carcinoma, Non-Small-Cell Lung · study director
- Ph3NCT07225946 · A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate CancerJanssen Research & Development, LLC · recruiting · Prostatic Neoplasms, Castration-Resistant · study director
- Ph3NCT07222761 · A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)Regeneron Pharmaceuticals · recruiting · Relapsed and/or Refractory Multiple Myeloma (RRMM) · study director
- Ph3NCT07220785 · Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized LipodystrophyRegeneron Pharmaceuticals · recruiting · Generalized Lipodystrophy · study director
- N/ANCT07220824 · A Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World SettingJanssen Research & Development, LLC · recruiting · Arthritis, Psoriatic · study director
- Ph3NCT07220772 · A Study Evaluating Mibavademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in Children, Adolescents and AdultsRegeneron Pharmaceuticals · recruiting · Monogenic Obesity · study director
- Ph1NCT07219212 · A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell CarcinomaJohnson & Johnson Enterprise Innovation Inc. · recruiting · Squamous Cell Carcinoma of Head and Neck · study director
- Ph1/Ph2NCT07218770 · A Study of REGN7041 for Active Noninfectious Uveitis in Adult ParticipantsRegeneron Pharmaceuticals · terminated · Active Noninfectious Uveitis Affecting the Posterior Segment · study director
- Ph3NCT07217587 · Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia GravisJanssen Research & Development, LLC · recruiting · Myasthenia Gravis · study director
- Ph1NCT07216066 · First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)Regeneron Pharmaceuticals · recruiting · Parkinsons Disease · study director
- Ph3NCT07213778 · REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult ParticipantsRegeneron Pharmaceuticals · recruiting · Symptomatic Venous Thromboembolism (VTE) · study director
- Ph2/Ph3NCT07196722 · A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's DiseaseJanssen Research & Development, LLC · recruiting · Crohn Disease · study director
- Ph3NCT07196748 · A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative ColitisJanssen Research & Development, LLC · active not recruiting · Colitis, Ulcerative · study director
- N/ANCT07194070 · A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global RegistryJanssen Research & Development, LLC · recruiting · Hemolytic Disease of the Fetus and Newborn · study director
- Ph1/Ph2NCT07187401 · A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 InhibitorRegeneron Pharmaceuticals · recruiting · Paroxysmal Nocturnal Hemoglobinuria (PNH), Persistent Anemia · study director
- Ph4NCT07187089 · Study of Growth and Bone Mineral Density in Children With Atopic Dermatitis (AD) Treated With DupilumabRegeneron Pharmaceuticals · withdrawn · Severe Atopic Dermatitis (AD) · study director
- Ph2NCT07175428 · Safety in Adult Participants With Atrial Fibrillation Who Are Treated With AnticoagulationRegeneron Pharmaceuticals · recruiting · Atrial Fibrillation (AF) · study director
- N/ANCT07174596 · Evaluation of Approved Contact LensesJohnson & Johnson Vision Care, Inc. · completed · Visual Acuity · study director
- Ph3NCT07164443 · A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)Janssen Research & Development, LLC · recruiting · Metastatic Castration-resistant Prostatic Neoplasms · study director
- N/ANCT07161635 · Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLsAlcon Research · completed · Aphakia, Presbyopia · study director
- Ph2NCT07154290 · A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)Regeneron Pharmaceuticals · recruiting · Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer · study director
- Ph3NCT07154745 · A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working EfficientlyRegeneron Pharmaceuticals · recruiting · Paroxysmal Nocturnal Hemoglobinuria · study director
- N/ANCT07147192 · Feasibility Study of an Accommodating IOL DesignAlcon Research · terminated · Aphakia · study director
- Ph4NCT07142343 · A Study to Test the Safety of Pozelimab in Pediatric Participants 1 to 5 Years of Age With a Rare Disease Called CHAPLE (Complement Hyperactivation, Angiopathic Thrombosis, Protein-losing Enteropathy) DiseaseRegeneron Pharmaceuticals · recruiting · CHAPLE Disease · study director
- Ph4NCT07141004 · A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)Johnson & Johnson Private Limited · recruiting · Arthritis, Psoriatic · study director
- N/ANCT07116525 · A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping CatheterBiosense Webster, Inc. · recruiting · Scar-related Atrial Tachycardia, Persistent Atrial Fibrillation, Paroxysmal Atrial Fibrillation · study director
- Ph3NCT07112378 · A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic EsophagitisRegeneron Pharmaceuticals · recruiting · Eosinophilic Esophagitis (EoE) · study director
- Ph3NCT07109869 · Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal CandidiasispH-D Feminine Health LLC · completed · Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital, Vulvovaginal Candidiasis (VVC) · study chair
- N/ANCT07105228 · Incidence of Retinal Vasculitis Among Patients Receiving Aflibercept: A US Real-World Evidence StudyRegeneron Pharmaceuticals · completed · Retinal Vasculitis · study director
- N/ANCT07102368 · A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in GermanyJanssen-Cilag G.m.b.H · recruiting · Inflammatory Bowel Disease, Colitis, Ulcerative, Crohn's Disease · study director
- Ph1NCT07082920 · A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate CancerJanssen Research & Development, LLC · recruiting · Prostatic Neoplasms · study director
- Ph3NCT07082816 · Reformulated PG324 Ophthalmic Solution for Intraocular Pressure ReductionAlcon Research · completed · Ocular Hypertension, Open Angle Glaucoma · study director
- N/ANCT07076160 · Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact LensesJohnson & Johnson Vision Care, Inc. · completed · Visual Acuity, Presbyopia · study director
- Ph1NCT07073183 · Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With Squamous Non Small-Cell Lung Cancer (sqNSCLC)CureVac · withdrawn · Squamous NSCLC · study director
- N/ANCT07054281 · UNITY VCS Vitreoretinal SurgeryAlcon Research · withdrawn · Epiretinal Membrane, Macular Hole, Visually Significant Vitreous Floater · study director
- Ph4NCT07053345 · A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant DepressionJanssen Korea, Ltd., Korea · completed · Depressive Disorder, Treatment-Resistant · study director
- N/ANCT07044674 · A Cataract Surgery Clinical TrialAlcon Research · withdrawn · Cataract · study director
- N/ANCT07036835 · Clinical Investigation of a Femtosecond Laser for Corneal Flap CreationAlcon Research · completed · Refractive Errors · study director
- Ph4NCT07030517 · A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple MyelomaJohnson & Johnson Private Limited · active not recruiting · Multiple Myeloma · study director
- Ph3NCT07015905 · REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in AdultsRegeneron Pharmaceuticals · recruiting · Venous Thromboembolism (VTE) · study director
- N/ANCT06987474 · Capella Scientia Development StudyAlcon Research · recruiting · Cataract · study director
- Ph1NCT06975787 · Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus NephritisRegeneron Pharmaceuticals · recruiting · Lupus Nephritis (LN) · study director
- Ph1NCT06970405 · Study of Safety and Effects of Garetosmab in Healthy Obese Men and Post-Menopausal WomenRegeneron Pharmaceuticals · withdrawn · Obesity · study director
- N/ANCT06967129 · Evaluation of Daily Disposable Toric Soft Lenses Manufactured With an Alternative Hydration ProcessJohnson & Johnson Vision Care, Inc. · completed · Astigmatism · study director
- Ph3NCT06919965 · A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder CancerJanssen Research & Development, LLC · recruiting · Non-Muscle Invasive Bladder Neoplasms · study director
- N/ANCT06884202 · Evaluation of Delefilcon A Contact LensesAlcon Research · completed · Refractive Errors, Myopia · study director
- Ph3NCT06878404 · A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic ArthritisJanssen Research & Development, LLC · active not recruiting · Arthritis, Psoriatic · study director
- N/ANCT06877676 · Pre-Approval Expanded Access Study for TAR-200 Treating Physician UseJanssen Research & Development, LLC · approved for marketing · Non-Muscle Invasive Bladder Neoplasms · study director
- N/ANCT06864858 · Clinical Evaluation of Two Cosmetic Contact LensesJohnson & Johnson Vision Care, Inc. · completed · Visual Acuity · study director
- Ph3NCT06852222 · A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)Janssen Research & Development, LLC · recruiting · Leukemia, Myeloid, Acute · study director
- Ph2NCT06848088 · A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma TreatmentRegeneron Pharmaceuticals · active not recruiting · Melanoma · study director
- Ph1/Ph2NCT06836609 · A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)Regeneron Pharmaceuticals · active not recruiting · Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis · study director
- Ph2NCT06833190 · REGN5381 in Adult Participants With Uncontrolled HypertensionRegeneron Pharmaceuticals · terminated · Uncontrolled Hypertension · study director
- Ph3NCT06807424 · A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic ArthritisJanssen Research & Development, LLC · active not recruiting · Arthritis, Psoriatic · study director
- Ph1/Ph2NCT06800313 · Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate CancerJanssen Research & Development, LLC · recruiting · Metastatic Prostate Cancer · study director
- N/ANCT06798298 · A Safety and Efficacy Long-Term Follow-up Study of Adult Participants Treated With Gene Modified T CellsRegeneron Pharmaceuticals · recruiting · Long Term Safety Following GM T Cell Therapy · study director
- Ph1NCT06788509 · A Rollover Study for Continued Study Treatment and Ongoing Safety MonitoringJanssen Research & Development, LLC · enrolling by invitation · Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin · study director
- Ph2NCT06787612 · Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian CancerRegeneron Pharmaceuticals · recruiting · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer · study director
- Ph1NCT06784349 · ALN-APOC3 in Adult Participants With DyslipidemiaRegeneron Pharmaceuticals · completed · Dyslipidemia · study director
- Ph2NCT06785012 · A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive DisorderJanssen Research & Development, LLC · completed · Depressive Disorder, Major · study director
- N/ANCT06784063 · Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs)Alcon Research · completed · Astigmatism · study director
- N/ANCT06778057 · Clinical Performance of Three Daily Disposable Silicone Hydrogel Contact LensesJohnson & Johnson Vision Care, Inc. · completed · Visual Acuity · study director
- Ph1NCT06768489 · A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple MyelomaJanssen Research & Development, LLC · recruiting · Multiple Myeloma, Smoldering Multiple Myeloma, Immunoglobulin Light-chain Amyloidosis · study director
- Ph2NCT06769698 · A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaRegeneron Pharmaceuticals · recruiting · Head and Neck Squamous Cell Carcinoma (HNSCC) · study director
- N/ANCT06749496 · Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over One Week of WearJohnson & Johnson Vision Care, Inc. · completed · Astigmatism · study director
- Ph3NCT06750094 · A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received ChemotherapyJanssen Research & Development, LLC · recruiting · Colorectal Neoplasms · study director
- Ph3NCT06741969 · Nipocalimab in Moderate to Severe Sjogren's DiseaseJanssen Research & Development, LLC · active not recruiting · Sjogrens Syndrome · study director
- Ph3NCT06706674 · Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric PatientsIntra-Cellular Therapies, Inc. · recruiting · Irritability Associated With Autism Spectrum Disorder · study director
- Ph2NCT06701903 · Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety DisorderIntra-Cellular Therapies, Inc. · recruiting · Generalized Anxiety Disorder · study director
- N/ANCT06693531 · A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of CareRegeneron Pharmaceuticals · active not recruiting · Eosinophilic Esophagitis (EoE) · study director
- Ph3NCT06690398 · Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric PatientsIntra-Cellular Therapies, Inc. · recruiting · Irritability Associated With Autism Spectrum Disorder · study director
- Ph1NCT06679998 · A Phase I Clinical Trial Evaluating the Safety, Tolerability and Pharmacokinetics of AAPB for InjectionJiangsu Kanion Pharmaceutical Co., Ltd · not yet recruiting · Acute Ischemic Stroke (AIS) · principal investigator
- Ph1NCT06669234 · Phase 1 Safety and Tolerability Study of ALN-F1202 in Healthy AdultsRegeneron Pharmaceuticals · completed · Healthy Volunteer · study director
- Ph1/Ph2NCT06669247 · A Study to Assess the Safety and Anti-Tumor Activity of REGN7945 in Combination With Linvoseltamab in Adult Participants With Relapsed/Refractory Multiple MyelomaRegeneron Pharmaceuticals · recruiting · Relapsed/Refractory Multiple Myeloma · study director
- Ph2NCT06667908 · A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)Johnson & Johnson Enterprise Innovation Inc. · recruiting · Carcinoma, Non-Small-Cell Lung · study director
- Ph2NCT06667076 · A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Janssen Research & Development, LLC · recruiting · Carcinoma, Non-Small-Cell Lung · study director
- N/ANCT06664788 · A Study of ETHIZIA Versus SURGICEL Original in Controlling Soft Tissue Bleeding During Open SurgeryEthicon, Inc. · completed · Hemostasis, Hemostatic Techniques · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.